{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:45Z","timestamp":1740144105947,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40268-023-00415-9","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T08:18:29Z","timestamp":1680077909000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-447X","authenticated-orcid":false,"given":"Raphael","family":"Allgaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Kandulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"G\u00fclow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke Christian","family":"Tews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"11","key":"415_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jcph.1512","volume":"59","author":"M Lutz","year":"2019","unstructured":"Lutz M. Metamizole (Dipyrone) and the liver: a review of the literature. J Clin Pharmacol. 2019;59(11):1433\u201342.","journal-title":"J Clin Pharmacol"},{"key":"415_CR2","volume":"7","author":"AS Ramacciotti","year":"2014","unstructured":"Ramacciotti AS, Soares BGO, Atallah AN. WITHDRAWN: dipyrone for acute primary headaches. Cochrane Database Syst Rev. 2014;7: CD004842.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"415_CR3","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.5504\/BBEQ.2012.0135","volume":"27","author":"I Nikolova","year":"2013","unstructured":"Nikolova I, Petkova V, Tencheva J, Benbasat N, Voinikov J, Danchev N. Metamizole: a review profile of a well-known \u201cforgotten\u201d drug. Part II: clinical profile. Biotechnol Biotechnol Equip. 2013;27(2):3605\u201319.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"2","key":"415_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2015","unstructured":"Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, et al. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol. 2015;71(2):219\u201327.","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"415_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2500\/aap.2012.33.3561","volume":"33","author":"A Uzzaman","year":"2012","unstructured":"Uzzaman A, Cho SH. Chapter 28: classification of hypersensitivity reactions. Allergy Asthma Proc. 2012;33(Suppl 1):96\u20139.","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"415_CR6","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.medcli.2016.06.008","volume":"147","author":"GPL Fern\u00e1ndez","year":"2016","unstructured":"Fern\u00e1ndez GPL, Ib\u00e1\u00f1ez CMF, L\u00f3pez PE. Severe thrombocytopenia and agranulocytosis associated with metamizole. Med Clin. 2016;147(8):e43\u20134.","journal-title":"Med Clin"},{"issue":"4","key":"415_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000444798","volume":"169","author":"N Blanca-L\u00f3pez","year":"2016","unstructured":"Blanca-L\u00f3pez N, P\u00e9rez-S\u00e1nchez N, Ag\u00fandez JA, Garc\u00eda-Martin E, Torres MJ, Cornejo-Garc\u00eda JA, et al. Allergic reactions to metamizole: immediate and delayed responses. Int Arch Allergy Immunol. 2016;169(4):223\u201330.","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"415_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","volume":"71","author":"T Stammschulte","year":"2015","unstructured":"Stammschulte T, Ludwig W-D, M\u00fchlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis: an analysis of German spontaneous reports 1990\u20132012. Eur J Clin Pharmacol. 2015;71(9):1129\u201338.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"415_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58(4):265\u201374.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"415_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/0895-4356(89)90116-9","volume":"42","author":"HA Guess","year":"1989","unstructured":"Guess HA. Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time. J Clin Epidemiol. 1989;42(12):1179\u201384.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"415_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0895-4356(89)90037-1","volume":"42","author":"OS Miettinen","year":"1989","unstructured":"Miettinen OS, Caro JJ. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol. 1989;42(4):325\u201331.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"415_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ams2.319","volume":"5","author":"T Hongo","year":"2018","unstructured":"Hongo T, Nozaki S, Tsuchiya M, Inaba M, Takahashi K, Fujiwara T. Contrast medium-induced transient severe leukopenia. Acute Med Surg. 2018;5(2):185\u20138.","journal-title":"Acute Med Surg"},{"issue":"4","key":"415_CR13","volume":"13","author":"HH Al Ghailani","year":"2021","unstructured":"Al Ghailani HH, Al Alawi AM, Al Hashim AH. Contrast media-induced immune hemolytic anemia. Cureus. 2021;13(4): e14522.","journal-title":"Cureus"},{"issue":"1","key":"415_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.510230105","volume":"23","author":"AJ Sanyal","year":"1996","unstructured":"Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology. 1996;23(1):32\u20139.","journal-title":"Hepatology"},{"issue":"1","key":"415_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/hep.510230123","volume":"23","author":"HO Conn","year":"1996","unstructured":"Conn HO. Hemolysis after transjugular intrahepatic portosystemic shunting: the naked stent syndrome. Hepatology. 1996;23(1):177\u201381.","journal-title":"Hepatology"},{"issue":"4","key":"415_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1155\/1996\/19343","volume":"9","author":"S Garcia-Rebollo","year":"1996","unstructured":"Garcia-Rebollo S, Gonz\u00e1lez-Reimers E, Santolaria-Fern\u00e1ndez F, Diaz-Romero F, Rodriguez-Moreno F, Martinez-Riera A. Transient hemolytic anemia after transjugular intrahepatic portosystemic stent shunt. HPB Surg. 1996;9(4):249\u201351.","journal-title":"HPB Surg"},{"issue":"2","key":"415_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1055\/s-0039-1688418","volume":"36","author":"A Kuei","year":"2019","unstructured":"Kuei A, Mikolajczyk AE, Niemeyer MM. Management of complications in IR: hemolytic anemia following stent-graft transjugular intrahepatic portosystemic shunt creation. Semin Interv Radiol. 2019;36(2):72.","journal-title":"Semin Interv Radiol"},{"key":"415_CR18","doi-asserted-by":"crossref","unstructured":"Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program; 2009. p. 73\u20139.","DOI":"10.1182\/asheducation-2009.1.73"},{"issue":"2","key":"415_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5858\/133.2.309","volume":"133","author":"B Kenney","year":"2009","unstructured":"Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med. 2009;133(2):309\u201314.","journal-title":"Arch Pathol Lab Med"},{"key":"415_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep23845","volume":"6","author":"A Ariza","year":"2016","unstructured":"Ariza A, Garc\u00eda-Mart\u00edn E, Salas M, Monta\u00f1ez MI, Mayorga C, Blanca-Lopez N, et al. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole. Sci Rep. 2016;6: 23845.","journal-title":"Sci Rep"},{"issue":"2","key":"415_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0006-2952(02)01511-3","volume":"65","author":"JM Garc\u00eda-Mart\u00ednez","year":"2003","unstructured":"Garc\u00eda-Mart\u00ednez JM, Fresno Vara JA, Lastres P, Bernab\u00e9u C, Bet\u00e9s PO, Mart\u00edn-P\u00e9rez J. Effect of metamizol on promyelocytic and terminally differentiated granulocytic cells: comparative analysis with acetylsalicylic acid and diclofenac. Biochem Pharmacol. 2003;65(2):209\u201317.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"415_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/biomedicines8070212","volume":"8","author":"D Rudin","year":"2020","unstructured":"Rudin D, Schmutz M, Roos NJ, Bouitbir J, Kr\u00e4henb\u00fchl S. Reactive metamizole metabolites enhance the toxicity of hemin on the ATP pool in HL60 cells by inhibition of glycolysis. Biomedicines. 2020;8(7):212.","journal-title":"Biomedicines."},{"issue":"6","key":"415_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/FPC.0000000000000432","volume":"31","author":"I Radulovic","year":"2021","unstructured":"Radulovic I, Dogan B, Dohna-Schwake C, Sch\u00fcndeln MM, Siffert W, M\u00f6hlendick B. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis. Pharmacogenet Genom. 2021;31(6):140\u20133.","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"415_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis BR. Drug-induced immune neutropenia\/agranulocytosis. Immunohematology. 2014;30(2):95\u2013101.","journal-title":"Immunohematology"},{"issue":"1","key":"415_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.29328\/journal.acr.1001019","volume":"3","author":"PD Saint-Cyr Sylvestre","year":"2019","unstructured":"Saint-Cyr Sylvestre PD, Clotaire ND, Emeraude NC, Kouakou B, Magloire CPS, Mamady D, et al. Fatal agranulocytosis associated with metamizole treatment in a 16-year-old girl. Arch Case Rep. 2019;3(1):35\u20137.","journal-title":"Arch Case Rep"},{"issue":"2","key":"415_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Kr\u00e4henb\u00fchl S, R\u00e4tz Bravo AE. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol. 2015;71(2):209\u201317.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"415_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther. 2016;41(5):459\u201377.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"415_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00482-014-1490-7","volume":"28","author":"C Lampl","year":"2014","unstructured":"Lampl C, Likar R. Metamizol: Wirkmechanismen, Interaktionen und Agranulozytoserisiko. Schmerz. 2014;28(6):584\u201390.","journal-title":"Schmerz"},{"issue":"1","key":"415_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","volume":"15","author":"E Andr\u00e8s","year":"2008","unstructured":"Andr\u00e8s E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008;15(1):15\u201321.","journal-title":"Curr Opin Hematol"},{"key":"415_CR30","doi-asserted-by":"crossref","unstructured":"Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics: the International Agranulocytosis and Aplastic Anemia Study. JAMA. 1986;256(13):1749\u201357.","DOI":"10.1001\/jama.256.13.1749"},{"issue":"4","key":"415_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00210-019-01774-4","volume":"393","author":"S Klose","year":"2020","unstructured":"Klose S, Pflock R, K\u00f6nig IR, Linder R, Schwaninger M. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(4):681\u201390.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"9","key":"415_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146(9):657\u201365.","journal-title":"Ann Intern Med"},{"issue":"10","key":"415_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1055\/a-1190-4445","volume":"99","author":"K Schinz","year":"2020","unstructured":"Schinz K, Waldfahrer F, W\u00fcst W, Iro H. Agranulozytose nach Metamizol-Einnahme: ein untersch\u00e4tztes Risiko? Laryngorhinootologie. 2020;99(10):707\u201312.","journal-title":"Laryngorhinootologie"},{"issue":"1","key":"415_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00482-016-0160-3","volume":"31","author":"UM Stamer","year":"2017","unstructured":"Stamer UM, Gundert-Remy U, Biermann E, Erlenwein J, Mei\u03b2ner W, Wirz S, et al. Metamizol: \u00dcberlegungen zum Monitoring zur fr\u00fchzeitigen Diagnose einer Agranulozytose. Schmerz. 2017;31(1):5\u201313.","journal-title":"Schmerz"},{"issue":"2","key":"415_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bcpt.13310","volume":"126","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann F, Bantel C, Jobski K. Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985\u20132017. Basic Clin Pharmacol Toxicol. 2020;126(2):116\u201325.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"415_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","volume":"140","author":"M Castells","year":"2017","unstructured":"Castells M. Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol. 2017;140(2):321\u201333.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-023-00415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-023-00415-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-023-00415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:35:10Z","timestamp":1687797310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-023-00415-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s40268-023-00415-9","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"type":"print","value":"1174-5886"},{"type":"electronic","value":"1179-6901"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"22 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Raphael Allgaier, Arne Kandulski, Karsten G\u00fclow, Lars Maier, Martina M\u00fcller, and Hauke Christian Tews have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The patient's informed consent was obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The patient's informed consent was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"RA wrote the manuscript with input from all authors and under the supervision of HCT. All authors contributed to the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}